INTERNATIONAL BIOTECHNOLOGY TRUST PLC
(the "Company")
The Company was notified on 7 November 2023 that Caroline Gulliver, Non-executive Director of the Company, purchased 2,500 Ordinary 25 pence shares in the capital of the Company at a price of 573.1516 pence per Ordinary share. As a result of this purchase, Caroline Gulliver's aggregate holding of shares in the Company is 12,000 Ordinary shares, representing 0.03% of the Company's issued share capital.
Notification of dealing form
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||
a) |
Name |
Caroline Gulliver |
|
2 |
Reason for the notification |
||
a) |
Position/status |
Non-executive Director of the Company |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
a) |
Name |
International Biotechnology Trust plc |
|
b) |
LEI |
213800N1QUJ744P76D11 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
a) |
Description of the financial instrument, type of instrument |
Ordinary shares |
|
Identification code |
GB0004559349 |
||
b) |
Nature of the transaction |
Share purchase |
|
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
573.1516p |
2,500 |
||
d) |
Aggregated information
|
Aggregated price |
Aggregated volume |
N/A |
N/A |
||
e) |
Date of the transaction |
07 November 2023 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |